Combination Chemotherapy, Monoclonal Antibody, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma

NCT00068250 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

60

Enrollment

NETWORK

Sponsor class

Conditions

Brain and Central Nervous System Tumors
Lymphoma

Interventions

DRUG: rituximab
DRUG: methotrexate
DRUG: temozolomide 100 mg/m^2
DRUG: temozolomide 150 mg/m^2
DRUG: temozolomide 200 mg/m^2
RADIATION: radiation therapy
DRUG: post-radiation therapy temozolomide

Sponsor

Radiation Therapy Oncology Group

Collaborators

[object Object]
[object Object]